Company / Net Debt per Share
RIGEL PHARMACEUTICALS INC Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.67
FY2025
5-year range
$0.01 / $0.67
FY2021-FY2025
Trend
+261.6%
vs FY2024
Sector context
#36 of 82
Health Care
What the data says
Net Debt per Share changed +262% YoY in FY2025, a notable deviation from the 6-year average annual change of +294%.
Based on SEC 10-K filings.
0.67 in FY2025 with a 3-year CAGR of +95.1%.
Increased from $0.16 to $0.67 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +95.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#47 of 82 in Health CareTop 56% of 82This company $0.67 Sector average $1.13
▼
-40.4% below sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's net debt per share has grown for 6 consecutive years.
- In FY2025, net debt per share increased 261.6% year-over-year.
- Ranks #36 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.67 | +261.6% |
| FY2024 | $0.19 | +18.6% |
| FY2023 | $0.16 | +73.3% |
| FY2022 | $0.09 | +1281.4% |
| FY2021 | $0.01 | +110.6% |
| FY2020 | -$0.06 | +17.6% |
| FY2019 | -$0.07 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026